AUC · k for variable inter-occasion CL [NCA / SHAM]

posted by PharmCat  – Russia, 2021-10-01 00:15 (23 d 05:38 ago) – Posting: # 22609
Views: 669

Hey!
Helmut,
Sounds great. One problem ... I don't think that our regulators will be able to understand this, or there will be a desire and dare to change the foundations. Also, I think NLME modeling can be applied.

Complete thread:

Activity
 Admin contact
21,753 posts in 4,548 threads, 1,544 registered users;
online 3 (0 registered, 3 guests [including 1 identified bots]).
Forum time: Sunday 05:53 CEST (Europe/Vienna)

They were “so intent of making everything numerical”
that they frequently missed seeing
what was there to be seen.    Barbara McClintock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5